相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-HIV Activity of Defective Cyanovirin-N Mutants Is Restored by Dimerization
Elena Matei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Evaluation of CD4-CD4i Antibody Architectures Yields Potent, Broadly Cross-Reactive Anti-Human Immunodeficiency Virus Reagents
Anthony P. West et al.
JOURNAL OF VIROLOGY (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Multivalent Interactions with gp120 Are Required for the Anti-HIV Activity of Cyanovirin
Yinan Liu et al.
BIOPOLYMERS (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections
Valence M. K. Ndesendo et al.
AAPS PHARMSCITECH (2008)
A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity
Raimund Fromme et al.
BIOCHEMISTRY (2007)
Virus glycosylation: role in virulence and immune interactions
David J. Vigerust et al.
TRENDS IN MICROBIOLOGY (2007)
Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition
Laura G. Barrientos et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa
Ming Li et al.
JOURNAL OF VIROLOGY (2006)
Engineered vaginal Lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N
Xiaowen Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans
Francois Helle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development
DM Colleluori et al.
PROTEIN EXPRESSION AND PURIFICATION (2005)
The highly specific carbohydrate-binding protein cyanovirin-N: Structure, anti-HIV/Ebola activity and possibilities for therapy
LG Barrientos et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity
LG Barrientos et al.
STRUCTURE (2004)
Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin
BR O'Keefe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
DA Calarese et al.
SCIENCE (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus
LG Barrientos et al.
ANTIVIRAL RESEARCH (2003)
Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: Calorimetric and NMR characterization
SR Shenoy et al.
CHEMISTRY & BIOLOGY (2002)
Functional homologs of cyanovirin-N amenable to mass production in prokaryotic and eukaryotic hosts
T Mori et al.
PROTEIN EXPRESSION AND PURIFICATION (2002)
Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides
I Botos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The domain-swapped dimer of cyanovirin-N is in a metastable folded state: Reconciliation of X-ray and NMR structures
LG Barrientos et al.
STRUCTURE (2002)
Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: Characterization of low affinity carbohydrate binding site knockout mutants
LC Chang et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Engineering an obligate domain-swapped dimer of cyanovirin-N with enhanced anti-HIV activity
BS Kelley et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Design and initial characterization of a circular permuted variant of the potent HIV-inactivating protein cyanovirin-N
LG Barrientos et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2002)
Solution structure of a cyanovirin-N:Manα1-2Manα complex:: Structural basis for high-affinity carbohydrate-mediated binding to gp120
CA Bewley
STRUCTURE (2001)
The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to man8 D1D3 and Man9 with nanomolar affinity:: Implications for binding to the HIV envelope protein gp120
CA Bewley et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
HIV-inhibitory natural products part 71 - Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner
AJ Bolmstedt et al.
MOLECULAR PHARMACOLOGY (2001)
Multiple antiviral activities of cyanovirin-N: Blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses
B Dey et al.
JOURNAL OF VIROLOGY (2000)
分享论文
